U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (TAD011)Cat. No. WA1888$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (TAD011)Cat. No. WA1888
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (SYN-004)Cat. No. WA1887
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (SCT200)Cat. No. WA1886
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (RC68)Cat. No. WA1885
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (MM-151)Cat. No. WA1884
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (KT112)Cat. No. WA1883
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (humMR1)Cat. No. WA1882
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (HTI-1511)Cat. No. WA1881
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (GC1118A)Cat. No. WA1880
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (DXL1218)Cat. No. WA1879
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (CMAB017)Cat. No. WA1878
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 (CMAB009)Cat. No. WA1877